Analysts’ Weekly Ratings Updates for Tenet Healthcare (THC)

Several brokerages have updated their recommendations and price targets on shares of Tenet Healthcare (NYSE: THC) in the last few weeks:

• 12/27/2025 – Tenet Healthcare was downgraded by analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating.
• 12/22/2025 – Tenet Healthcare had its “hold (c+)” rating reaffirmed by analysts at Weiss Ratings.
• 12/18/2025 – Tenet Healthcare had its “overweight” rating reaffirmed by analysts at Morgan Stanley. They now have a $247.00 price target on the stock.
• 12/15/2025 – Tenet Healthcare was downgraded by analysts at Weiss Ratings from a “buy (b-)” rating to a “hold (c+)” rating.
• 12/8/2025 – Tenet Healthcare had its “buy (b-)” rating reaffirmed by analysts at Weiss Ratings.
• 12/2/2025 – Tenet Healthcare had its price target raised by analysts at Guggenheim from $238.00 to $257.00. They now have a “buy” rating on the stock.
• 12/1/2025 – Tenet Healthcare had its “buy (b-)” rating reaffirmed by analysts at Weiss Ratings.
• 11/24/2025 – Tenet Healthcare had its “buy (b-)” rating reaffirmed by analysts at Weiss Ratings.
• 11/21/2025 – Tenet Healthcare had its price target raised by analysts at Barclays PLC from $229.00 to $240.00. They now have an “overweight” rating on the stock.
• 11/17/2025 – Tenet Healthcare had its “buy (b-)” rating reaffirmed by analysts at Weiss Ratings.
• 11/13/2025 – Tenet Healthcare had its price target raised by analysts at JPMorgan Chase & Co. from $200.00 to $230.00. They now have an “overweight” rating on the stock.
• 11/13/2025 – Tenet Healthcare had its price target raised by analysts at Wells Fargo & Company from $238.00 to $252.00. They now have an “overweight” rating on the stock.
• 11/11/2025 – Tenet Healthcare was upgraded by analysts at Weiss Ratings from a “hold (c+)” rating to a “buy (b-)” rating.
• 11/3/2025 – Tenet Healthcare had its “buy” rating reaffirmed by analysts at Truist Financial Corporation. They now have a $240.00 price target on the stock, up previously from $225.00.
• 10/30/2025 – Tenet Healthcare had its price target raised by analysts at Royal Bank Of Canada from $230.00 to $252.00. They now have an “outperform” rating on the stock.

Insider Activity at Tenet Healthcare

In related news, Director Tammy Romo sold 645 shares of the stock in a transaction that occurred on Wednesday, November 5th. The shares were sold at an average price of $205.20, for a total transaction of $132,354.00. Following the completion of the sale, the director owned 34,866 shares of the company’s stock, valued at approximately $7,154,503.20. This represents a 1.82% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Richard W. Fisher sold 2,500 shares of Tenet Healthcare stock in a transaction that occurred on Wednesday, October 29th. The shares were sold at an average price of $208.43, for a total transaction of $521,075.00. Following the transaction, the director directly owned 8,792 shares in the company, valued at approximately $1,832,516.56. This trade represents a 22.14% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 45,500 shares of company stock valued at $9,247,071 over the last three months. Insiders own 0.81% of the company’s stock.

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.